A Study to Evaluate the Efficacy, Safety, and Immunogenicity of an EV71 Vaccine

Clinical trial NCT03865238 · COMPLETED

Trial details

NCT number: NCT03865238
Sponsor: Medigen Vaccine Biologics Corp.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Enterovirus 71 Infection

Start date: 2019-04-23
Primary completion: 2021-04-16
Enrollment: 3061

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.